diclofenac sodium and misoprostol tablet delayed release
american health packaging - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 75 mg
diclofenac 50 mg/misoprostol 200 micrograms modified release tablets
morningside healthcare ltd - diclofenac sodium; misoprostol - modified-release tablet - 50 mg/200 microgram(s) - acetic acid derivatives and related substances; diclofenac, combinations
diclofenac potassium 50 mg film-coated tablets
accord healthcare limited - diclofenac potassium - film-coated tablet - 50 milligram(s) - acetic acid derivatives and related substances; diclofenac
diclofenac potassium 50mg tablets
alliance healthcare (distribution) ltd - diclofenac potassium - oral tablet - 50mg
diclofenac potassium 50mg tablets
phoenix healthcare distribution ltd - diclofenac potassium - oral tablet - 50mg
diclofenac 25
dr reddy's new zealand limited - diclofenac potassium 25mg - film coated tablet - 25 mg - active: diclofenac potassium 25mg excipient: crospovidone macrogol 6000 magnesium stearate mannitol opadry clear potassium bicarbonate sodium laurilsulfate - diclofenac 25 tablets are indicated for the short-term treatment of the following acute conditions: · post-traumatic pain, inflammation and swelling, e.g. due to sprains · post-operative pain, inflammation and swelling, e.g. following dental or orthopaedic surgery · painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis · migraine attacks · painful syndromes of the vetebral column · non-articular rheumatism · as an adjuvant in severe painful inflammatory infections of the ear, nose or throat, e.g. pharyngotonsillitis, otitis. in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. fever alone is not an indication. diclofenac should only be prescribed when the benefits are considered to outweigh the potential risks.
diclofenac potassium nch
glaxosmithkline consumer healthcare (ireland) limited - diclofenac potassium - film coated tablet - 12.5 milligram - diclofenac
diclofenac sodium gel
ipg pharmaceuticals, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 30 mg in 1 g - diclofenac sodium gel is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. diclofenac sodium gel is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol, polyethylene glycol monomethyl ether 350 and/or hyaluronate sodium. diclofenac sodium gel is contraindicated in the following patients: - in the setting of coronary artery bypass graft (cabg) surgery.
diclofenac sodium gel
actavis pharma, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 30 mg in 1 g - diclofenac sodium topical gel is indicated for the topical treatment of actinic keratosis (ak). diclofenac sodium topical gel is contraindicated in the following patients: - with known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product [see warnings and precautions (5.1, 5.3, 5.10) and description (11)] - with the history of asthma, urticaria, or other allergic type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.1, 5.2)] - application on damaged skin resulting from any etiology, including exudative dermatitis, eczema, infected lesions, burns or wounds [see warnings and precautions (5.3)] - in the setting of coronary bypass graft (cabg) surgery [see warnings and precautions (5.4)] risk summary use of nsaids, including diclofenac sodium can cause premature closure of the fetal ductus arteriosus and fetal ren
diclofenac sodium gel
pharmaceutica north america, inc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 30 mg in 1 g - diclofenac sodium gel is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. diclofenac sodium gel is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol, polyethylene glycol monomethyl ether 350 and/or hyaluronate sodium.